19-40398770-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000324001.8(PRX):āc.231C>Gā(p.Tyr77Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ). Synonymous variant affecting the same amino acid position (i.e. Y77Y) has been classified as Likely benign.
Frequency
Consequence
ENST00000324001.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.231C>G | p.Tyr77Ter | stop_gained | 6/7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.516C>G | p.Tyr172Ter | stop_gained | 6/7 | NP_001398056.1 | ||
PRX | NM_020956.2 | c.231C>G | p.Tyr77Ter | stop_gained | 6/6 | NP_066007.1 | ||
PRX | XM_017027047.2 | c.129C>G | p.Tyr43Ter | stop_gained | 3/4 | XP_016882536.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRX | ENST00000324001.8 | c.231C>G | p.Tyr77Ter | stop_gained | 6/7 | 1 | NM_181882.3 | ENSP00000326018 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247616Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134102
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461780Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 727212
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74346
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2020 | The p.Y77* pathogenic mutation (also known as c.231C>G), located in coding exon 3 of the PRX gene, results from a C to G substitution at nucleotide position 231. This changes the amino acid from a tyrosine to a stop codon within coding exon 3. This alteration was detected in a neuropathy cohort; however, clinical details were limited (DiVincenzo C et al. Mol Genet Genomic Med, 2014 Nov;2:522-9). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Charcot-Marie-Tooth disease type 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 03, 2023 | This sequence change creates a premature translational stop signal (p.Tyr77*) in the PRX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRX are known to be pathogenic (PMID: 11133365). This variant is present in population databases (rs752192677, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with neuropathy (PMID: 25614874). ClinVar contains an entry for this variant (Variation ID: 574671). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at